Protege drug — proposed autoimmune medication — trials suspended
Eli Lilly and MacroGenics announced that they have suspended phase III trials of Protégé, a drug designed to address the autoimmune component in people with
Eli Lilly and MacroGenics announced that they have suspended phase III trials of Protégé, a drug designed to address the autoimmune component in people with